Funder: National Institutes of Health
Due Dates: August 26, 2025 (Letter of Intent) | September 25, 2025 (Full Application)
Funding Amounts: Up to $300,000 direct costs per year for up to 5 years (maximum $1.5M direct costs total), plus applicable F&A costs.
Summary: Supports early stage investigators with innovative genetics or epigenetics research on substance use disorders, especially those lacking preliminary data for an R01.
Key Information: Applicants must be Early Stage Investigators (ESI) in an independent research position at a U.S. institution; multiple PD/PIs are not allowed.